Related Experiment Video
Updated: Nov 15, 2025

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
BK Polyomavirus Micro-RNAs: Time Course and Clinical Relevance in Kidney Transplant Recipients
Baptiste Demey1,2, Véronique Descamps1,2, Claire Presne3
1Laboratoire de Virologie, Centre Hospitalier Universitaire, F-80000 Amiens, France.
Background:
Kidney transplant recipients (KTRs) are exposed to a high risk of BK polyomavirus (BKPyV) replication, which in turn may lead to graft loss. Although the microRNAs (miRNAs) bkv-miR-B1-3p and bkv-miR-B1-5p are produced during the viral cycle, their putative value as markers of viral replication has yet to be established. In KTRs, the clinical relevance of the changes over time in BKPyV miRNA levels has not been determined.
Methods:
In a retrospective study, we analyzed 186 urine samples and 120 plasma samples collected from 67 KTRs during the first year post-transplantation. Using a reproducible, standardized, quantitative RT-PCR assay, we measured the levels of bkv-miR-B1-3p and bkv-miR-B1-5p (relative to the BKPyV DNA load).
Results:
Detection of the two miRNAs had low diagnostic value for identifying patients with DNAemia or for predicting DNAuria during follow-up. Seven of the 14 KTRs with a sustained BKPyV infection within the first year post-transplantation showed a progressive reduction in the DNA load and then a rapid disappearance of the miRNAs. DNA and miRNA loads were stable in the other seven KTRs.
Conclusions:
After the DNA-based diagnosis of BKPyV infection in KTRs, bkv-miR-B1-3p and bkv-miR-B1-5p levels in the urine might be valuable markers for viral replication monitoring and thus might help physicians to avoid an excessive reduction in the immunosuppressive regimen.
Insights
BK polyomavirus (BKPyV) microRNAs (miRNAs) show potential for monitoring viral replication in kidney transplant recipients. While not ideal for initial diagnosis, their levels can help guide immunosuppression adjustments after BKPyV infection is confirmed.
Area of Science:
- Virology
- Transplantation Immunology
- Molecular Diagnostics
Background:
- Kidney transplant recipients (KTRs) face high risk of BK polyomavirus (BKPyV) replication, potentially causing graft loss.
- BKPyV produces specific microRNAs (miRNAs), bkv-miR-B1-3p and bkv-miR-B1-5p, during its replication cycle.
- The clinical utility of these BKPyV miRNAs as markers for viral replication in KTRs remains undetermined.
Purpose of the Study:
- To investigate the clinical relevance of BKPyV-specific miRNA levels in KTRs.
- To assess the potential of bkv-miR-B1-3p and bkv-miR-B1-5p as markers for BKPyV replication.
- To determine if these miRNAs can aid in managing immunosuppression in KTRs.
Main Methods:
- Retrospective analysis of 186 urine and 120 plasma samples from 67 KTRs within the first year post-transplantation.
- Quantitative RT-PCR assay used to measure bkv-miR-B1-3p and bkv-miR-B1-5p levels relative to BKPyV DNA load.
- Comparison of miRNA levels with BKPyV DNAemia and DNAuria status.
Main Results:
- Detection of bkv-miR-B1-3p and bkv-miR-B1-5p showed limited diagnostic value for initial BKPyV detection or predicting future viral shedding.
- In KTRs with sustained BKPyV infection, a progressive decrease and subsequent disappearance of miRNAs were observed in some cases.
- Stable DNA and miRNA loads were noted in other KTRs with persistent BKPyV infection.
Conclusions:
- BKPyV-specific miRNAs may serve as valuable markers for monitoring viral replication after initial DNA-based diagnosis in KTRs.
- Monitoring urinary bkv-miR-B1-3p and bkv-miR-B1-5p levels could assist clinicians in adjusting immunosuppressive therapy.
- These miRNAs might help avoid excessive immunosuppression reduction, thereby preserving graft function.
More Related Videos
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
05:39Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Related Concept Videos
Kidney Transplant I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management
Acute Kidney Injury II: Pathophysiology
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease II: Clinical Manifestations